Paul Tudor Jones’s Avidity Biosciences RNAM Stock Holding History

Paul Tudor Jones’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$218K	–	3971
2025 Q3	$218K	Buy	+5,000	New	+$202K	﹤0.01%	3164

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Paul Tudor Jones's RNAM Position: Q1 2026 in Review

Paul Tudor Jones sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 733,010 shares — an estimated $52.9M sold.

Paul Tudor Jones first reported a position in RNAM in Q2 2022 and held it in 9 quarters. The position peaked at $52.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Paul Tudor Jones reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Paul Tudor Jones sold 733,010 Avidity Biosciences shares in Q1 2026, an estimated $52.9M.
Paul Tudor Jones first reported a position in Avidity Biosciences in Q2 2022 and held it in 9 quarters.
Paul Tudor Jones's Avidity Biosciences position peaked at $52.9M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.